Sorrell aftermath: New legal challenges to FDA speech restrictions


Legal challenges to FDA regulations -- specifically the agency's ban on off-label promotion -- are emerging in the wake of the U.S. Supreme Court decision in Sorrell v. IMS Health. Read more about the recent legal actions, and how they may redefine off-label promotional activities, in an article posted on the Coalition for Healthcare Communication website, courtesy of The RPM Report.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
Washington DC, DC